276 related articles for article (PubMed ID: 33851013)
1. Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors and a Ketogenic Diet: A Case Series and Review of Literature.
Mistry S; Eschler DC
AACE Clin Case Rep; 2021; 7(1):17-19. PubMed ID: 33851013
[TBL] [Abstract][Full Text] [Related]
2. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
Sarno MJF; Hernandez DPF; Matulac MO
Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
[TBL] [Abstract][Full Text] [Related]
3. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Diaz-Ramos A; Eilbert W; Marquez D
Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
[TBL] [Abstract][Full Text] [Related]
4. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].
Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M
Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745
[TBL] [Abstract][Full Text] [Related]
5. Fall, Fracture, and Two Episodes of Euglycemic Diabetic Ketoacidosis.
Wasey W; Hutchings S; Dufner A; Okon D; Saleh S
Cureus; 2022 Jun; 14(6):e25788. PubMed ID: 35812537
[TBL] [Abstract][Full Text] [Related]
6. Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis.
Dutta S; Kumar T; Singh S; Ambwani S; Charan J; Varthya SB
J Family Med Prim Care; 2022 Mar; 11(3):927-940. PubMed ID: 35495849
[TBL] [Abstract][Full Text] [Related]
7. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
Patel K; Nair A
Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
[TBL] [Abstract][Full Text] [Related]
8. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.
Vitale RJ; Valtis YK; McDonnell ME; Palermo NE; Fisher NDL
AACE Clin Case Rep; 2021; 7(1):10-13. PubMed ID: 33521255
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
Chauhan S; Manov A; Dhillon GS; Shah P
Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
[TBL] [Abstract][Full Text] [Related]
10. Euglycemic Diabetic Ketoacidosis in the Setting of SGLT2 Inhibitor Use and Hypertriglyceridemia: A Case Report and Review of Literature.
Gajjar K; Luthra P
Cureus; 2019 Apr; 11(4):e4384. PubMed ID: 31218148
[TBL] [Abstract][Full Text] [Related]
11. Delayed euDKA Associated With Dapagliflozin After Pancreatitis.
Wu G; Wu S; Tang J; Wu H
Clin Ther; 2023 Jul; 45(7):e167-e170. PubMed ID: 37248092
[TBL] [Abstract][Full Text] [Related]
12. The Significance of Precise Diabetes Diagnosis: A Case of Euglycemic Diabetic Ketoacidosis Induced by the Introduction of Empagliflozin with Simultaneous Reduction of Insulin Dosage.
Bińczyk W; Dróżdż O; Siudek B; Głuszczyk AM; Plizga JI; Grajnert FJ
Eur J Case Rep Intern Med; 2024; 11(6):004567. PubMed ID: 38846667
[TBL] [Abstract][Full Text] [Related]
13. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
[TBL] [Abstract][Full Text] [Related]
14. A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet.
Dorcely B; Nitis J; Schwartzbard A; Newman JD; Goldberg IJ; Sum M
Curr Diabetes Rev; 2021; 17(2):243-246. PubMed ID: 32178617
[TBL] [Abstract][Full Text] [Related]
15. SUCCESSFUL REIMPLEMENTATION OF A VERY LOW CARBOHYDRATE KETOGENIC DIET AFTER SGLT2 INHIBITOR ASSOCIATED EUGLYCEMIC DIABETIC KETOACIDOSIS.
Fieger EI; Fadel KM; Modarres AH; Wickham EP; Wolver SE
AACE Clin Case Rep; 2020; 6(6):e330-e333. PubMed ID: 33244496
[TBL] [Abstract][Full Text] [Related]
16. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports.
Khedr A; Hennawi HA; Khan MK; Eissa A; Mir M; Rauf I; Nitesh J; Surani S; Khan SA
World J Clin Cases; 2023 Aug; 11(24):5700-5709. PubMed ID: 37727728
[TBL] [Abstract][Full Text] [Related]
17. A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery.
Osafehinti DA; Okoli OJ; Karam JG
AACE Clin Case Rep; 2021; 7(1):20-22. PubMed ID: 33851014
[TBL] [Abstract][Full Text] [Related]
18. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Dull RB; Spangler ML; Knezevich EL; Lau BM
J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
[TBL] [Abstract][Full Text] [Related]
19. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
[TBL] [Abstract][Full Text] [Related]
20. Sodium-glucose cotransporter-2 (SGLT2) inhibitor-induced euglycemic diabetic ketoacidosis complicating the perioperative management of a patient with type 2 diabetes mellitus (T2DM) and Fournier's gangrene: A case report.
Lindsay PJ; Gibson LE; Bittner EA; Berg S; Chang MG
Int J Surg Case Rep; 2020; 77():463-466. PubMed ID: 33395826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
